Xvivo Perfusion AB (OSTO:XVIVO) Total Operating Expense : kr545.8 Mil (TTM As of Mar. 2025)

View and export this data going back to 2012. Start your Free Trial

What is Xvivo Perfusion AB Total Operating Expense?

Xvivo Perfusion AB's Total Operating Expense for the three months ended in Mar. 2025 was kr133.8 Mil. Xvivo Perfusion AB's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was kr545.8 Mil.

Xvivo Perfusion AB Total Operating Expense Historical Data

The historical data trend for Xvivo Perfusion AB's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xvivo Perfusion AB Total Operating Expense Chart

Xvivo Perfusion AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Operating Expense

Get a 7-Day Free Trial

173.92

207.02

292.50

439.72

527.01

Xvivo Perfusion AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Operating Expense	Get a 7-Day Free Trial															116.11	124.82	127.46	159.67	133.81

Xvivo Perfusion AB Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr545.8 Mil.

Xvivo Perfusion AB Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Xvivo Perfusion AB's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Xvivo Perfusion AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xvivo Perfusion AB (OSTO:XVIVO) » Definitions » Total Operating Expense

Comparable Companies

Traded in Other Exchanges

XVIPF:USA XVIVOs:UK 0RKL:UK 3XV:Germany

Address

Gemenskapens gata 9, Molndal, SWE, SE-431 53

Website

https://www.xvivoperfusion.com

Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all of the majority organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.

Xvivo Perfusion AB Headlines

No Headlines